CKPT logo

Checkpoint Therapeutics (CKPT) EBITDA

Annual EBITDA

-$52.15 M
+$6.18 M+10.60%

December 31, 2023

Summary

Performance

1-Year Change

+10.6%

3-Year Change

-124.77%

5-Year Change

-41.94%

15-Year Change

-128.97%

CKPT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.54%
CKPT annual EBITDA is higher than 31.54% of companies in Healthcare sector

High & Low

All-time High

-$13.66 M

3-Year Low

-$58.33 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CKPT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 21, 2025
CKPT next annual earnings announcement is scheduled for Mar 21, 2025

OtherCKPTprofitabilitymetrics:

Annual Revenue

$103.00 K
CKPT annual revenue is $103.00 thousand

Annual Net Income

-$51.85 M
CKPT annual net profit is -$51.85 million

Annual EBIT

-$52.15 M
CKPT annual earnings before interest & taxes is -$52.15 million

Annual EPS

-$3.17
CKPT annual earnings per share is -$3.17

Quarterly EBITDA

-$9.72 M
-$3.05 M-45.72%

September 30, 2024

Summary

Performance

3-Month Change

-45.72%

1-Year Change

-26.27%

3-Year Change

+8.81%

5-Year Change

-191.05%

CKPT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.36%
CKPT quarterly EBITDA is higher than 36.36% of companies in Healthcare sector

High & Low

All-time High

-$3.26 M

3-Year Low

-$29.77 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CKPT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 21, 2025
CKPT next earnings announcement is scheduled for Mar 21, 2025

OtherCKPTprofitabilitymetrics:

Quarterly Revenue

-
CKPT quarterly revenue value is unknown

Quarterly Net Income

-$9.72 M
CKPT quarterly net profit is -$9.72 million

Quarterly EBIT

-$9.72 M
CKPT quarterly earnings before interest & taxes is -$9.72 million

Quarterly EPS

-$0.23
CKPT quarterly earnings per share is -$0.23

TTM EBITDA

-$37.51 M
-$2.02 M-5.70%

September 30, 2024

Summary

Performance

3-Month Change

-5.7%

1-Year Change

+36.01%

3-Year Change

+47.5%

5-Year Change

-68.53%

CKPT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.29%
CKPT TTM EBITDA is higher than 37.29% of companies in Healthcare sector

High & Low

All-time High

-$3.68 M

3-Year Low

-$72.07 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CKPT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 21, 2025
CKPT next earnings announcement is scheduled for Mar 21, 2025

OtherCKPTprofitabilitymetrics:

TTM Revenue

-
CKPT TTM revenue value is unknown

TTM Net Income

-$46.47 M
CKPT TTM net profit is -$46.47 million

TTM EBIT

-$37.51 M
CKPT TTM earnings before interest & taxes is -$37.51 million

TTM EPS

-$1.84
CKPT TTM earnings per share is -$1.84

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$52.15 M
CKPT annual EBITDA is -$52.15 million

Annual Net Income

-$51.85 M
CKPT annual net profit is -$51.85 million

Annual Interest Expense

-
CKPT annual interest expense value is unknown

Annual Income Tax

-
CKPT annual income tax value is unknown

Annual D&A

-
CKPT annual depreciation & amortization value is unknown

CKPT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.6%-26.3%+36.0%
3 y3 years-124.8%+8.8%+47.5%
5 y5 years-41.9%-191.1%-68.5%

CKPT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+10.6%-45.7%+67.3%-5.7%+48.0%
5 y5-year-124.8%+10.6%-191.1%+67.3%-72.0%+48.0%
alltimeall time-281.8%+10.6%-198.2%+67.3%-919.7%+48.0%

Checkpoint Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.72 M(+45.7%)
-$37.51 M(+5.7%)
Jun 2024
-
-$6.67 M(-39.0%)
-$35.49 M(-21.2%)
Mar 2024
-
-$10.95 M(+7.7%)
-$45.01 M(-13.7%)
Dec 2023
-$52.15 M(-10.6%)
-$10.17 M(+32.0%)
-$52.15 M(-11.0%)
Sep 2023
-
-$7.70 M(-52.4%)
-$58.62 M(-4.8%)
Jun 2023
-
-$16.20 M(-10.4%)
-$61.59 M(+3.4%)
Mar 2023
-
-$18.08 M(+8.6%)
-$59.55 M(+2.1%)
Dec 2022
-$58.33 M(+2.8%)
-$16.64 M(+56.1%)
-$58.33 M(-18.4%)
Sep 2022
-
-$10.66 M(-24.7%)
-$71.46 M(-0.9%)
Jun 2022
-
-$14.16 M(-16.0%)
-$72.07 M(+7.5%)
Mar 2022
-
-$16.86 M(-43.4%)
-$67.07 M(+18.2%)
Dec 2021
-$56.72 M(+144.5%)
-$29.77 M(+164.0%)
-$56.72 M(+52.5%)
Sep 2021
-
-$11.28 M(+23.2%)
-$37.20 M(+20.5%)
Jun 2021
-
-$9.16 M(+40.5%)
-$30.86 M(+17.0%)
Mar 2021
-
-$6.52 M(-36.4%)
-$26.38 M(+13.7%)
Dec 2020
-$23.20 M
-$10.24 M(+107.2%)
-$23.20 M(+6.3%)
Sep 2020
-
-$4.94 M(+5.8%)
-$21.82 M(-1.3%)
Jun 2020
-
-$4.67 M(+39.9%)
-$22.11 M(-0.7%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$3.34 M(-62.3%)
-$22.26 M(-10.4%)
Dec 2019
-$24.85 M(-32.4%)
-$8.86 M(+69.2%)
-$24.85 M(-10.9%)
Sep 2019
-
-$5.23 M(+8.4%)
-$27.89 M(-13.0%)
Jun 2019
-
-$4.83 M(-18.6%)
-$32.04 M(-5.5%)
Mar 2019
-
-$5.93 M(-50.1%)
-$33.89 M(-7.8%)
Dec 2018
-$36.74 M(+61.3%)
-$11.89 M(+26.7%)
-$36.74 M(+19.3%)
Sep 2018
-
-$9.39 M(+40.6%)
-$30.79 M(+12.6%)
Jun 2018
-
-$6.68 M(-24.0%)
-$27.35 M(+0.8%)
Mar 2018
-
-$8.78 M(+47.9%)
-$27.14 M(+19.2%)
Dec 2017
-$22.77 M(+3.0%)
-$5.94 M(-0.2%)
-$22.77 M(-9.5%)
Sep 2017
-
-$5.95 M(-8.1%)
-$25.16 M(+3.4%)
Jun 2017
-
-$6.47 M(+46.6%)
-$24.34 M(+4.6%)
Mar 2017
-
-$4.41 M(-47.0%)
-$23.27 M(+5.2%)
Dec 2016
-$22.12 M(+61.9%)
-$8.32 M(+62.3%)
-$22.12 M(+2.0%)
Sep 2016
-
-$5.13 M(-5.1%)
-$21.68 M(+7.2%)
Jun 2016
-
-$5.41 M(+65.7%)
-$20.23 M(+36.5%)
Mar 2016
-
-$3.26 M(-58.6%)
-$14.83 M(+28.2%)
Dec 2015
-$13.66 M
-$7.89 M(+114.4%)
-$11.56 M(+214.4%)
Sep 2015
-
-$3.68 M
-$3.68 M

FAQ

  • What is Checkpoint Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Checkpoint Therapeutics?
  • What is Checkpoint Therapeutics annual EBITDA year-on-year change?
  • What is Checkpoint Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Checkpoint Therapeutics?
  • What is Checkpoint Therapeutics quarterly EBITDA year-on-year change?
  • What is Checkpoint Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Checkpoint Therapeutics?
  • What is Checkpoint Therapeutics TTM EBITDA year-on-year change?

What is Checkpoint Therapeutics annual EBITDA?

The current annual EBITDA of CKPT is -$52.15 M

What is the all time high annual EBITDA for Checkpoint Therapeutics?

Checkpoint Therapeutics all-time high annual EBITDA is -$13.66 M

What is Checkpoint Therapeutics annual EBITDA year-on-year change?

Over the past year, CKPT annual EBITDA has changed by +$6.18 M (+10.60%)

What is Checkpoint Therapeutics quarterly EBITDA?

The current quarterly EBITDA of CKPT is -$9.72 M

What is the all time high quarterly EBITDA for Checkpoint Therapeutics?

Checkpoint Therapeutics all-time high quarterly EBITDA is -$3.26 M

What is Checkpoint Therapeutics quarterly EBITDA year-on-year change?

Over the past year, CKPT quarterly EBITDA has changed by -$2.02 M (-26.27%)

What is Checkpoint Therapeutics TTM EBITDA?

The current TTM EBITDA of CKPT is -$37.51 M

What is the all time high TTM EBITDA for Checkpoint Therapeutics?

Checkpoint Therapeutics all-time high TTM EBITDA is -$3.68 M

What is Checkpoint Therapeutics TTM EBITDA year-on-year change?

Over the past year, CKPT TTM EBITDA has changed by +$21.11 M (+36.01%)